Bona fide valuation choice on physician samples may avoid penalty, though duty and interest can still survive.

Physician samples valued under the cost control method and by reference to pro-rata sale pack value were examined in the context of central excise valuation. The text notes that the valuation issue had been considered capable of more than one bona fide view until later settled by a Larger Bench; on that basis, adoption of one plausible valuation method did not justify penalty under Rule 25. At the same time, the duty liability and interest on the disputed valuation were maintained, while the penal consequence was removed. The stated principle is that a bona fide interpretative choice on valuation may not attract penalty, even if the duty position ultimately survives.

---

---

Issues: (i) Whether the duty liability and interest confirmed on physician samples cleared by applying pro-rata value of the sale pack were sustainable. (ii) Whether penalty was exigible under Rule 25 of the Central Excise Rules, 2002 for the manner in which valuation was adopted.

Issue (i): Whether the duty liability and interest confirmed on physician samples cleared by applying pro-rata value of the sale pack were sustainable.

Analysis: The appellant had valued physician samples by following the cost control method under the valuation rules. The issue on valuation of physician samples had already been settled by a Larger Bench, and until that settlement, more than one view on valuation was possible. In such a situation, adoption of one plausible view on valuation could not be treated as faultworthy for the purpose of fastening the duty demand and interest.

Conclusion: The confirmation of duty liability and interest was upheld and the assessee did not succeed on this issue.

Issue (ii): Whether penalty was exigible under Rule 25 of the Central Excise Rules, 2002 for the manner in which valuation was adopted.

Analysis: Since the valuation controversy admitted of two possible views at the relevant time, the appellant's choice of one view in valuing physician samples was not a ground to visit it with penal consequences. The conduct did not justify invocation of penalty when the dispute was one of interpretation on valuation methodology.

Conclusion: The penalty imposed under Rule 25 of the Central Excise Rules, 2002 was set aside in favour of the assessee.

Final Conclusion: The dispute was sustained on duty and interest, but the penal consequence was removed, resulting in only a partial relief to the assessee.

Ratio Decidendi: Where the valuation issue is capable of more than one bona fide view at the relevant time, adoption of one such view does not warrant penalty, though the duty demand on the finally accepted valuation position may still survive.

---